Being tested
Cell therapy or transplant: reduce relapses and new lesions in MS (type not specified)
MS (type not specified) · Cell therapy or transplant
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 1
- Running now
- 1
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Stem cell transplantation, trial | Not a drug-phase study | 20 | 2026 | Still running | Not counted: not randomised |
Counted: 0. Will count later: 0. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Being tested
Related hypotheses
- Cell therapy or transplant: prevent attacks in NMOSD
- Cell therapy or transplant: reduce relapses and new lesions in primary progressive MS
- Cell therapy or transplant: reduce relapses and new lesions in relapsing MS
- Cell therapy or transplant: reduce relapses and new lesions in relapsing and progressive MS
- Cell therapy or transplant: reduce relapses and new lesions in secondary progressive MS
Assembled by software from public sources.